ACADIA PHARMACEUTICALS INCACAD

Market cap

$3.9B

P/E ratio

	Dec 31, 2011	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	7	58	12	62	102	164	69	135	190	326	147	115	189	320
Investment securities, available-for-sale	24	-	174	261	113	365	272	339	508	306	373	302	250	436
Accounts receivable, net	-	-	-	-	-	6	17	26	36	48	64	62	98	99
Interest Receivable, Current	-	-	-	1	2	1	1	2	2	2	1	1	4	6
Inventory	-	-	-	-	-	-	-	-	-	-	8	7	36	22
Prepaid expenses	-	-	-	-	-	-	8	21	19	26	24	21	39	56
Total current assets	32	109	188	325	219	548	373	526	760	718	618	508	616	938
Property and equipment, net	0	0	1	1	2	3	3	3	3	9	8	6	5	4
Operating lease right-of-use assets	-	-	-	-	-	-	-	-	10	47	58	56	52	47
Intangible assets, net	-	-	-	-	-	-	-	-	-	-	-	-	65	120
Restricted cash	-	-	-	-	-	-	-	5	5	6	6	6	6	9
Long-term inventory	-	-	-	-	-	-	-	-	-	-	6	5	5	70
Other assets	0	-	0	0	0	1	0	2	3	2	4	8	0	0
Total assets	32	109	189	325	222	561	385	540	783	783	700	588	749	1,188
Accounts payable	2	1	0	2	2	4	9	3	7	8	7	13	18	16
Accrued liabilities	4	4	7	14	20	36	40	56	68	97	89	113	237	379
Total current liabilities	6	6	7	16	22	43	49	60	75	106	96	126	254	395
Operating lease liabilities	-	-	-	-	-	-	-	-	6	44	56	53	48	42
Other long-term liabilities	-	-	-	-	-	-	-	-	3	5	7	9	15	18
Total liabilities	9	6	7	16	22	43	49	61	84	156	159	187	317	455
Common Stock, Value, Issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Additional paid-in capital	-	-	-	-	-	-	1,559	1,948	2,403	2,613	2,695	2,771	2,863	2,937
Accumulated deficit	-347	-368	-406	-498	-663	-934	-1,224	-1,469	-1,704	-1,986	-2,154	-2,370	-2,431	-2,204
Accumulated other comprehensive income	0	0	0	-0	0	0	-0	-0	0	0	-0	-1	0	0
Total stockholders’ equity	23	85	182	309	200	518	335	479	699	627	541	400	432	733
Total liabilities and stockholders’ equity	32	109	189	325	222	561	385	540	783	783	700	588	749	1,188